Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Smith

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
U.S. Army Medical Department Journal|January 22, 2010
Stabilization and reconstruction operations: the role of the US Army Veterinary CorpsJohn C Smith
The Journal of the Arkansas Medical Society|February 11, 2015
The legendary Smiths and their Paris hospitalTaylor Prewitt, John C Smith, J P Bell
Cureus|December 12, 2022
Right Lower Extremity Osteomyelitis With Alcaligenes faecalis in a Patient With Poorly Controlled Type 2 Diabetes MellitusJohn C Smith, Marco Comianos, Wesley Tang, et al.
Pediatric Dermatology|March 20, 2015
Agminated flexural melanocytic nevi: a late sequela of Langerhans cell histiocytosis?Stephanie Feldstein, Tracy Funk, John C Smith, et al.
Plos One|March 12, 2014
KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasomeElana S Ehrlich, Jennifer C Chmura, John C Smith, et al.
Cancers|January 23, 2024
Correction: Smith et al. MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models. <i>Cancers</i> 2023, <i>15</i>, 3309John C Smith, Stefan Husted, Jay Pilrose, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
MCAK Inhibitors Induce Aneuploidy in Triple Negative Breast Cancer ModelsJohn C Smith, Stefan Husted, Jay Pilrose, et al.
Cancers|July 14, 2023
MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer ModelsJohn C Smith, Stefan Husted, Jay Pilrose, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranibJohn C Smith, Laura Brooks, Paulo M Hoff, et al.
Pharmacogenetics and Genomics|November 16, 2007
Tacrine-induced liver damage: an analysis of 19 candidate genesAna Alfirevic, Tracy Mills, Daniel Carr, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
U.S. Army Medical Department Journal|January 22, 2010
Stabilization and reconstruction operations: the role of the US Army Veterinary CorpsJohn C Smith
The Journal of the Arkansas Medical Society|February 11, 2015
The legendary Smiths and their Paris hospitalTaylor Prewitt, John C Smith, J P Bell
Cureus|December 12, 2022
Right Lower Extremity Osteomyelitis With Alcaligenes faecalis in a Patient With Poorly Controlled Type 2 Diabetes MellitusJohn C Smith, Marco Comianos, Wesley Tang, et al.
Pediatric Dermatology|March 20, 2015
Agminated flexural melanocytic nevi: a late sequela of Langerhans cell histiocytosis?Stephanie Feldstein, Tracy Funk, John C Smith, et al.
Plos One|March 12, 2014
KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasomeElana S Ehrlich, Jennifer C Chmura, John C Smith, et al.
Cancers|January 23, 2024
Correction: Smith et al. MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models. <i>Cancers</i> 2023, <i>15</i>, 3309John C Smith, Stefan Husted, Jay Pilrose, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
MCAK Inhibitors Induce Aneuploidy in Triple Negative Breast Cancer ModelsJohn C Smith, Stefan Husted, Jay Pilrose, et al.
Cancers|July 14, 2023
MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer ModelsJohn C Smith, Stefan Husted, Jay Pilrose, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranibJohn C Smith, Laura Brooks, Paulo M Hoff, et al.
Pharmacogenetics and Genomics|November 16, 2007
Tacrine-induced liver damage: an analysis of 19 candidate genesAna Alfirevic, Tracy Mills, Daniel Carr, et al.
Pageof 2